Res. Asst. PhDNaziye AK


Istanbul Medical Faculty, Division of Medical Sciences

Department of Internal Medicine


Research Areas: Medicine, Health Sciences, Internal Medicine Sciences, Internal Diseases, Oncology

Metrics

Publication

43

Citation (WoS)

23

H-Index (WoS)

4

Citation (Scopus)

26

H-Index (Scopus)

4

Project

1

Open Access

3
UN Sustainable Development Goals

Education Information

2017 - Continues

2017 - Continues

Post Doctorate of Medicine

Istanbul University, İstanbul Tıp Fakultesi-Onkoloji Enstitüsü, Tıbbi Onkoloji, Turkey

2012 - 2016

2012 - 2016

Expertise In Medicine

Istanbul University, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Turkey

2005 - 2011

2005 - 2011

Undergraduate

Istanbul University, Cerrahpaşa Tıp Fakültesi, İngilizce Tıp, Turkey

Dissertations

2016

2016

Expertise In Medicine

MEME KANSERİNDE NEOADJUVAN KEMOTERAPİ YANITINI PREDİKTE EDEN PATOLOJİK FAKTÖRLER Sustainable Development

Istanbul University, Cerrahpaşa Tıp Fakultesi, İç Hastalıkları Anabilim Dalı

Certificates, Courses and Trainings

2018

2018

PSİKOONKOLOJİ 2. DÜZEY KLİNİSYEN EĞİTİMİ

Education Management and Planning

PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ

2017

2017

AİLE DANIŞMANLIĞI

Education Management and Planning

ULUDAĞ ÜNİVERSİTESİ-UZAKTAN EĞİTİM

2017

2017

İMMUNOONKOLOJİ KURSU

Health&Medicine

TÜRK TIBBİ ONKOLOJİ DERNEĞİ

2017

2017

PSİKOONKOLOJİ 1. DÜZEY KLİNİSYEN EĞİTİMİ

Education Management and Planning

PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ

Research Areas

Medicine

Health Sciences

Internal Medicine Sciences

Internal Diseases

Oncology

Academic Titles / Tasks

2017 - Continues

2017 - Continues

Research Assistant

Istanbul University, Istanbul Medical Faculty, Tıbbi Onkoloji

Published journal articles indexed by SCI, SSCI, and AHCI

2021

2021

Nivolumab treatment for metastatic thymic epithelial tumors.

Ak N., Aydiner A.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.27, pp.1710-1715, 2021 (SCI-Expanded) identifier identifier identifier

2021

2021

Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center

Ak N., Toker A., Kara M., Ozkan B., Ulker M., Kaba E., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.29, no.4, pp.487-495, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

2021

2021

Skeletal system as a rare metastatic site in patients with ovarian carcinoma

Ak N. , Minareci Y. , Saip P.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.31, no.8, pp.1125-1131, 2021 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

2021

2021

Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.

Paksoy N., Erdem S., Karaca M., Ak N., Pehlivan M., Yirgin İ., et al.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, no.0, 2021 (SCI-Expanded) identifier identifier identifier

Articles Published in Other Journals

2021

2021

Nectin-2 and Nectin-4 Adhesion Molecules in Patients with Breast Cancer

Ak N., Serilmez M., Ucuncu M. Z. , Bademler S., Vatansever S.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.36, no.2, pp.165-170, 2021 (ESCI) Sustainable Development identifier identifier

Refereed Congress / Symposium Publications in Proceedings

2019

2019

Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study

Karabulut S., Dogan I., Ak N. , Afsar C. U. , Karabulut M., Tastekin D.

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.305 Sustainable Development identifier

2019

2019

Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study

AK N.

European Society for Medical Oncology Congress 2019, Barcelona, Spain, 27 September - 01 October 2019, pp.424-430 Sustainable Development

2019

2019

THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY

AK N.

World Conferrence of Lung Cancer 2019, Barcelona, Spain, 7 - 10 September 2019, pp.933-934

2019

2019

OUTCOMES OF THYMOMA AND DETERMINANTS OF SURVIVAL: 16 YEARS EXPERIENCE OF A TERTIARY CANCER CENTER

AK N.

World Conferrence of Lung Cancer, Barcelona, Spain, 7 - 10 September 2019, pp.1095-1096

2019

2019

Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels

Tuzer O. C. , Sari M., Aktas E., Ak N. , Buyukozturk S., Colakoglu B., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.737-738 identifier

2019

2019

Significance of adiposity in endometrial cancer prognosis.

KIZILDAĞ YIRGIN İ., ENGİN G., ÇELİK E., TOPUZ S., AK N., SAİP P.

Türk manyetik rezonans derneği.24.Uluslararası katılımlı yıllık bilimsel toplantısı. 2019, Ankara, Turkey, 25 - 27 April 2019 Sustainable Development

2018

2018

Platin ile hızlı desensitizasyonun sitokin düzeylerine etkisi P -29

Tüzer Ö. C. , Sarı M., ÇETİN E., Ak N., BÜYÜKÖZTÜRK S., ÇOLAKOĞLU B., et al.

XXV. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, pp.111

2013

2013

IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu

BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E. , AR M. C. , et al.

39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 - 26 October 2013, no.261, pp.277-278

2012

2012

IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu

BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E. , AR M. C. , et al.

38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, no.261, pp.277-278

Books & Book Chapters

2019

2019

Endometrium Kanserleri

AK N.

in: Klinik Çalışmalarla Onkolojide Hedefli Tedaviler, CİHAN S, GEREDELİ Ç, DEMİR C., Editor, Tıbbi Yayınlar Merkezi, İstanbul, pp.113-122, 2019

2019

2019

Systemic Treatment Drugs/Regimens and Dose Modifications

AK N.

in: Breast Disease, Aydiner A., Igci A., Soran A., Editor, Springer, Cham, Isviçre, pp.789-801, 2019

2018

2018

Systemic Treatment Drugs and Regimens

AK N.

in: Breast Cancer A Guide to Clinical Practice, Aydiner A, Igci A, Soran A., Editor, Springer International Publishing, Copyright Holder Springer Nature Switzerland Ag, pp.587-608, 2018 Sustainable Development